Adventitial versus intimal liposome-mediated ex vivo transfection of canine saphenous vein grafts with endothelial nitric oxide synthase gene

Journal of Vascular Surgery

Volumn 32, Issue 6, 2000, Pages 1190-1200

  Kalra, Manju ^a   Jost, Corey J ^a   Severson, Sandra R ^a   Miller, Virginia M ^b,c  

^a Departments of Surgery and Biophysics

^b Dept of of Gynecol and Obstet Physiol Compar Medicine and Biochemistry and Molecular Biology   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; LIPOFECTAMINE; LIPOSOME; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLASMID DNA;

ADVENTITIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; DOG; ENDOTHELIUM CELL; FEMORAL ARTERY; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; INTIMA; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAPHENOUS VEIN GRAFT; VEIN GRAFT;

EID: 0033637975     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2000.109211     Document Type: Article

References (44)

1. Characteristics and anatomic distribution of lesions that cause reversed vein graft failure: A five-year prospective study
2. An arginine analog inhibits responses of both the endothelium and smooth muscle of canine in situ vein grafts
3. Chronic changes in blood flow alter endothelium-dependent responses in autogenous vein grafts in dogs
4. Nitric oxide synthase and adenylyl and guanylyl cyclase activity in porcine interposition vein grafts
5. Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothdium-dependent acetylcholine-induced relaxation after arterial injury
6. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine
7. Explanted vein grafts with an intact endothelium demonstrate reduced focal expression of endothelial nitric oxide synthase specific to atherosclerotic sites
8. Endothelium-specific in vivo gene transfer
9. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector
10. High-efficiency gene transfer to autologous rabbit jugular vein grafts using adenovirus-transferrin/polylysine-DNA complexes
11. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors
12. Efficient and selective adenovirus-mediated gene transfer into vascular neointima
13. Expression and function of a recombinant endothelial nitric oxide synthase gene in porcine coronary arteries
14. Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery
15. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene
16. Gene transfer in vivo with DNA-liposome complexes: Lack of autoimmunity and gonadal localization
17. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
18. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis
19. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation
20. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung
21. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo
22. Time course of recombinant protein secretion after liposome-mediated gene transfer in a rabbit arterial organ culture model
23. Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues
24. Modulation of endothelium-derived nitric oxide in canine femoral veins
25. Role of nitric oxide in the control of apoptosis in the microvasculature
26. Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation
27. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts
28. Vascular gene transfer of the human inducible nitric oxide synthase: Characterization of activity and effects on myointimal hyperplasia
29. Recombinant endothelial nitric oxide synthase-transduced human saphenous veins: Gene therapy to augment nitric oxide production in bypass conduits
30. Genetic engineering of vein grafts resistant to atherosclerosis
31. Adenoviral-mediated gone transfer of a constitutively active form of the retinoblastoma gene product attenuates neointimal thickening in experimental vein grafts
32. Efficient adenoviral gene transfer to early venous bypass grafts: Comparison with native vessels
33. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts
34. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia
35. Cationic liposome-mediated gene transfer
36. Adventitial gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries alters vascular reactivity
37. Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium
38. Enhanced endothelium-dependent relaxations after gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries
39. Expression and function of recombinant endothelial nitric oxide synthase in coronary artery smooth muscle cells
40. Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery
41. Blood flow and kinetics of smooth muscle cell proliferation in canine autogenous vein grafts: In vivo BrdU incorporation
42. Tetrahydrobiopterin and endothelial function
43. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms
44. Remodeling of autologous saphenous vein grafts: The role of perivascular myofibroblasts